Progress of oral care and reduction of oral mucositis-a pilot study in a hematopoietic stem cell transplantation ward

被引:30
作者
Soga, Yoshihiko [1 ]
Sugiura, Yuko [1 ]
Takahashi, Kanayo [2 ]
Nishimoto, Hitomi [2 ]
Maeda, Yoshinobu [3 ]
Tanimoto, Mitsune [3 ]
Takashiba, Shogo [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol, Okayama 7008525, Japan
[2] Okayama Univ Hosp Med & Dent, Dept Nursing, Okayama 7008525, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama 7008525, Japan
基金
日本学术振兴会;
关键词
Oral care; Supportive care; Oral mucositis; Hematopoietic stem cell transplantation; PREVENTION; GUIDELINES;
D O I
10.1007/s00520-010-1002-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral mucositis is a common symptomatic complication associated with hematopoietic stem cell transplantation (HCT). We use simple strategies aimed to reduce oral mucositis by keeping the oral cavity clean and moist. Here, we report on the progress of oral care and the changes in the degree of oral mucositis. The purpose of this pilot study is to evaluate the effects of our strategies on the prevalence and the severity of oral mucositis. Fifty-three consecutive patients from 2003 to 2006 administered with conventional allogeneic HCT were enrolled in this study. The degree of oral mucositis was evaluated daily in all patients. Our oral care program was divided into two periods: "examination and trial period (2003 and 2004)" and "intensive oral care period (2005 and 2006)." In the latter, an oral care regimen was carried out systematically by a multidisciplinary team. Using our oral care strategies, the prevalence of ulcerative oral mucositis was decreased significantly. The rate was reduced from 76% (10 of 13) of patients with ulcerative oral mucositis in 2003 to only 20% (3 of 15) in 2006. Our pilot study suggests that oral mucositis in HCT patients can be alleviated by simple strategies aimed at keeping the oral cavity clean and moist.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 10 条
[1]  
[Anonymous], COMM TERM CRIT ADV E
[2]  
Bellm LA, 2000, SUPPORT CARE CANCER, V8, P33
[3]  
Bensinger William, 2008, J Natl Compr Canc Netw, V6 Suppl 1, pS1
[4]  
BOROWSKI B, 1994, ORAL ONCOL, V30B, P93
[5]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[6]   Updated clinical practice guidelines for the prevention and treatment of mucositis [J].
Keefe, Dorothy M. ;
Schubert, Mark M. ;
Elting, Linda S. ;
Sonis, Stephen T. ;
Epstein, Joel B. ;
Raber-Durlacher, Judith E. ;
Migliorati, Cesar A. ;
McGuire, Deborah B. ;
Hutchins, Ronald D. ;
Peterson, Douglas E. .
CANCER, 2007, 109 (05) :820-831
[7]  
RANSIER A, 1995, CANCER NURS, V18, P393
[8]   Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation [J].
Sonis, ST ;
Oster, G ;
Fuchs, H ;
Bellm, L ;
Bradford, WZ ;
Edelsberg, J ;
Hayden, V ;
Eilers, J ;
Epstein, JB ;
LeVeque, FG ;
Miller, C ;
Peterson, DE ;
Schubert, MM ;
Spijkervet, FKL ;
Horowitz, M .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2201-2205
[9]   The pathobiology of mucositis [J].
Sonis, ST .
NATURE REVIEWS CANCER, 2004, 4 (04) :277-284
[10]   Antimicrobial effects of the saliva substitute, Oralbalance®, against microorganisms from oral mucosa in the hematopoietic cell transplantation period [J].
Sugiura, Yuko ;
Soga, Yoshihiko ;
Tanimoto, Ichiro ;
Kokeguchi, Susumu ;
Nishide, Sachiko ;
Kono, Kotoe ;
Takahashi, Kanayo ;
Fujii, Nobuharu ;
Ishimaru, Fumihiko ;
Tanimoto, Mitsune ;
Yamabe, Kokoro ;
Tsutani, Soichiro ;
Nishimura, Fusanori ;
Takashiba, Shogo .
SUPPORTIVE CARE IN CANCER, 2008, 16 (04) :421-424